Sanofi Pasteur related Press Releases

Intanza®, the First Intradermal Influenza Vaccine, receives the European Marketing Authorisation Intanza®, the first seasonal flu vaccine delivered by intradermal microinjection, has been

... Read more...

LYON, France, February 17 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today that it is sponsoring a phase II... Read more...

INTANZA® / IDflu®, first intradermal influenza vaccine recommended in the European Union Lyon, France - December 18, 2008 - Sanofi Pasteur, the vaccines division of sanofi-aventis Group,

... Read more...

PARIS, November 12 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that Russia has chosen inactivated polio vaccine (IPV) from Sanofi Pasteur... Read more...

Sanofi Pasteur First International Vaccine Company to Enter Japan With Pediatric Vaccine ActHIB (Haemophilus Influenzae Type b Vaccine) Available in Japan on December 19, 2008 LYON, France, November

... Read more...

Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients PARIS, and TORONTO, Sept 17, 2008 -- PARIS, and TORONTO, Sept. 17 /PRNewswire/ -- Sanofi pasteur, the vaccines... Read more...

Crucell Enters Agreement with Sanofi Pasteur for Next-generation Biologicals against Rabies Exclusive agreement for rabies monoclonal antibodies to fight fatal disease Leiden, The Netherlands, 3... Read more...

Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine CAMBRIDGE, England and CAMBRIDGE, Massachusetts, November 1 - No Human Vaccine Currently Exists Against the West Nile... Read more...